section name header

Information

See Mechanism of Action of Select Antiarrhythmics table.

Pharmacologic Profile

General Use

Suppression of cardiac arrhythmias.


General Action and Information

MECHANISM OF ACTION OF SELECT ANTIARRHYTHMICS
DRUGMECHANISM
LidocaineClass Ib (Na channel blocker)
Esmolol, metoprolol, and propranololClass II (beta blockers: AV nodal conduction and automaticity)
AmiodaroneClass III (K channel blocker; also has Na channel, beta receptor, and Ca channel blocking properties)
Diltiazem and verapamilClass IV (nondihydropyridine calcium channel blockers: AV nodal conduction)
AdenosineRestores sinus rhythm by slowing conduction and interrupting re-entrant pathways in the AV node
AtropineInhibits the action of acetylcholine at postganglionic sites located in the heart HR
DigoxinSA and AV nodal conduction

1 AV = atrioventricular; Ca = calcium; K = potassium; Na = sodium; SA = sinoatrial.

Contraindications

Differ greatly among various agents. See individual drugs.


Precautions

Differ greatly among agents used. Appropriate dosage adjustments should be made in older adults and those with renal or hepatic impairment, depending on agent chosen. Correctable causes of arrhythmias (electrolyte abnormalities, drug toxicity) should be evaluated. See individual drugs.


Interactions

Differ greatly among agents used. See individual drugs.


Nursing Implications

Assessment

  • Monitor ECG, HR, and BP continuously throughout IV administration and periodically throughout oral administration.

Implementation

  • Take HR before administration of oral doses. Withhold dose and notify physician or other health care provider if HR <50 bpm.

Patient/Family Teaching

  • Instruct patient to take oral doses around the clock, as directed, even if feeling better.
  • Instruct patient or family member on how to take pulse. Advise patient to report changes in pulse rate or rhythm to health care provider.
  • Caution patient to avoid taking OTC medications without consulting health care provider.
  • Advise patient to carry identification describing disease process and medication regimen at all times.
  • Emphasize the importance of follow-up exams to monitor progress.

Evaluation/Desired Outcomes

  • Resolution of cardiac arrhythmias without detrimental side effects.

Antiarrhythmics included in Davis's Drug Guide for Nurses